Efficiency of low dose aspirin for prevention of complications for in vitro fertilization cycles of the patient with polycystic ovarian syndrome

Efficiency of low dose aspirin for prevention of ovarian hyper stimulation syndrome for in vitro fertilization cycles of the patient with polycystic ovarian syndrome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201105216541N1

Enrollment

Registered

2011-06-18

Start date

2011-05-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: For the intervention group 100mg/day asprin will be started since the 21th day of the previous cycle. Intervention 2: A placebo with a similar shape will be started for the control gro

Treatment - Drugs

Placebo

For the intervention group 100mg/day asprin will be started since the 21th day of the previous cycle.

A placebo with a similar shape will be started for the control group since the 21th day of previous cycle.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: polycystic ovarian syndrome (PCOS) confirmed by: Hyperandrogenism (clinical and/or biochemical); Ovarian dysfunction (oligo-anovulation and/or polycystic ovaries); The exclusion of other androgen excess or related disorders. Exclusion criteria: All of the patients with Known hypersensitivity to ASA or previous gastritis or GI bleeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of follicles. Timepoint: every 3-4 days. Method of measurement: by Ultra sound scan.;Serum Estradiol. Timepoint: every 3-4 days. Method of measurement: serum level of Estradiol.	—

Secondary

Measure	Time frame
Ovarian size more than 5 cm. Timepoint: 3-4 days. Method of measurement: ultra sound.;Ovarian size more than12 cm. Timepoint: 3-4 days. Method of measurement: ultra sound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bahia Namavar Jahromi

Infertility research center, Shiraz university of Medical Sciences

namavarb@sums.ac.ir+98 71 1233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026